FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Sponsor: Centre Hospitalier Universitaire de Besancon